Safety and Efficacy of GLP-1 Receptor Agonists in Type 2 Diabetes Mellitus with Advanced and End-Stage Kidney Disease: A Systematic Review and Meta-Analysis

Safety and Efficacy of GLP-1 Receptor Agonists in Type 2 Diabetes Mellitus with Advanced and End-Stage Kidney Disease: A Systematic Review and Meta-Analysis

<i><b>Background and Objectives</b></i>: Limited evidence exists regarding the safety and efficacy of glucagon-like peptide-1 receptor agonists (GLP-1RAs) in type 2 diabetes mellitus (T2DM) patients with advanced chronic kidney disease (CKD) or end-stage kidney disease (ESKD)...

Full description

Bibliographic Details
Main Authors: Pajaree Krisanapan, Kanokporn Sanpawithayakul, Pattharawin Pattharanitima, Charat Thongprayoon, Jing Miao, Michael A. Mao, Supawadee Suppadungsuk, Supawit Tangpanithandee, Iasmina M. Craici, Wisit Cheungpasitporn
Format: Article
Language:English
Published: MDPI AG 2024-01-01
Series:Diseases
Subjects:
glucagon-like peptide-1 receptor agonist
GLP-1RAs
advanced CKD
CKD stage5
end-stage kidney disease
ESKD
Online Access:https://www.mdpi.com/2079-9721/12/1/14

Internet

https://www.mdpi.com/2079-9721/12/1/14

Similar Items